SafeTy and Outcome of contemPorary Treatment Strategies for Cardiogenic SHOCK - an International, Observational Registry
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 2,500
- 试验地点
- 1
- 主要终点
- All-cause mortality
研究概览
简要总结
International, observational registry to investigate the outcome in patients with cardiogenic shock. The primary aim of this study is to investigate the clinical outcome of patients in cardiogenic shock.
详细描述
There is a focus on interventional therapies, mechanical circulatory support and new cardiovascular therapeutics in patients with cardiogenic shock (CS). The investigators will describe current practice in study sites including concomitant patients with CS. Therefore, the investigators will monitor drug therapies initiated, devices being utilized as well as outcome and side effect of possible interventions
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with cardiogenic shock treated at a tertiary care hospital.
排除标准
- •Age ≤17 years.
结局指标
主要结局
All-cause mortality
时间窗: Within 30 days after admission.
by registration office
次要结局
- Ischemic events, bleeding events, heart failure, sepsis, dialysis.(Within 12 months after admission.)
- All-cause mortality(Within 12 months after admission.)
研究者
PD Dr. Dirk Westermann
Professor
Universitätsklinikum Hamburg-Eppendorf